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The Longitude Prize 2014 is a challenge with a 
£10 million (~ZAR180 million) prize fund to help 
solve one of the greatest issues of our time.[1] The 
chosen issue is antimicrobial resistance (AMR) and 
the challenge is to create a cost-effective, accurate, 
rapid and easy-to-use test for bacterial infections. Clearly, this is a very 
important problem that has yet to be fully solved. 
Overuse of antibiotics, either because of unnecessary initiation 
or excessive duration, is a key driver of AMR. The rational use of 
existing diagnostic tests and development of new technologies to help 
clinicians confirm or exclude bacterial infection have an important 
role in improving antibiotic prescribing practices, ultimately improving 
patient outcomes and reducing AMR. 
The first ever bacteriological diagnosis was made in 1676, when 
Anton van Leeuwenhoek observed bacteria using a single-lens 
microscope and Robert Koch later advanced the science by focusing 
on pure culture of organisms. Since then, there has been great 
progress in these techniques and modern laboratories now also 
include state-of-the-art molecular diagnostics. This article describes 
the breadth of diagnostics currently available for bacterial infection 
and introduces some newer technologies that are on the horizon. 
Bacterial infection
Bacterial infection is primarily a clinical concept that may require the 
use of supportive bedside or laboratory tests to confirm or exclude. 
There are two broad factors that are always necessary to confirm the 
diagnosis: 
• inflammation or systemic dysfunction; and
• direct or indirect evidence of a compatible bacterial pathogen.
Inflammation may be localised or result in a systemic inflammatory 
response syndrome (SIRS) (Box 1). Sepsis refers to the presence of a 
SIRS response caused by presumed or confirmed infection. Severe 
sepsis occurs if there is accompanying organ dysfunction and septic 
shock in the case of hypotension requiring ionotropic support. 
However, these definitions have recently been criticised; e.g. in one 
study of >100  000 patients with confirmed infection and organ 
failure, 12% did not meet the criteria for SIRS.[2] 
Signs of inflammation are nonspecific, i.e. not limited to bacterial 
infection, and may be a consequence of non-bacterial infections, 
trauma, autoimmune diseases or drug reactions. Examples of symptoms 
associated with local inflammation include dysuria in urinary tract 
infection and skin redness in cellulitis, but both of these symptoms 
could also be due to non-infectious causes. Pancreatitis is the classic 
example of a SIRS response that mimics sepsis, but does not require 
antibiotics. At the opposite end of the spectrum, bacterial organisms 
that are recovered from non-sterile sites or other sites without 
evidence of local inflammation do not necessarily imply infection. 
For example, a superficial skin swab may culture Staphylococcus 
aureus, a highly pathogenic and lethal organism, from up to 30% of 
otherwise healthy people,[3] but does not require antibiotic therapy. 
Similarly, the finding of nitrites on a urine disptick in the absence of 
symptoms or urine leucocytes may suggest asymptomatic bacteriuria 
or bacterial contamination, but not infection. Certain pathogens, 
however, are considered to be pathological when detected from any site 
(Mycobacterium tuber culosis is the most important example).
The definition of bacterial infection, and assessing the need for 
antibiotic therapy, therefore requires clinicians to combine symptoms 
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Box 1. Definition of the systemic inflammatory response 
syndrome (SIRS)
SIRS is defined as the presence of any 2 of the following 4 criteria:
• Temperature <36 ºC or >38ºC
• Pulse >90 beats/min
• Respiratory rate >20 breaths/min; or arterial partial pressure of 
carbon dioxide <4.3 kPa
• White blood cell count <4 000 cells/mm³ or >12 000 cells/mm³; 
or the presence of >10% immature neutrophils (band forms)
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and signs of inflammation with diagnostic tests for direct or indirect 
evidence of a pathogen as a cause of the inflammation.
Diagnostic tests
The diagnostic process begins with a full clinical evaluation 
(history and examination), followed by bedside or laboratory-based 
investigations. Each has advantages and disadvantages, but they are 
rarely employed in isolation. The typical process begins with clinical 
tests and uses this information to guide bedside tests, followed by 
laboratory tests – with the probability of the diagnosis shifting with 
each piece of added information. Bacterial infection can occur in 
any part of the body with multiple different organisms and therefore 
the number of available tests is vast. This review discusses broad 
categories of tests, with specific examples to illustrate the process.
Clinical diagnostics
In general, single clinical parameters are neither sensitive nor specific 
for bacterial infection. For example, fever is common in bacterial 
infection, but also often absent, and may be caused by a multitude 
of other illnesses, e.g. as part of the SIRS response. Therefore, it is 
usual to group together features from the history and examination to 
create useful case definitions. Usually case definitions are designed 
to have high sensitivity but low specificity so that the condition is 
‘ruled out’ in patients not fitting the definition. Further testing is 
then usually required to ‘rule in’ the diagnosis. An example is the 
case definition of acute meningitis: <7 days of at least two of the four 
cardinal features (fever, confusion, headache and neck stiffness). 
This is useful to exclude patients who are very unlikely to have acute 
meningitis, but further testing with a lumbar puncture is required to 
rule in the condition. 
Not all case definitions have low specificity and are sometimes 
the sole basis for confirming a diagnosis. For example, the case 
definition for community-acquired pneumonia, which includes a 
chest radiograph, is fever and/or breathlessness or tachypnoea and/
or tachycardia as well as new or progressive infiltrate on a chest 
radiograph. Patients fulfilling this case definition are considered to 
have pneumonia, and the condition is excluded in patients to whom 
the case definition does not apply. Further bedside or laboratory 
testing is not required to confirm the diagnosis, but may be useful for 
monitoring purposes. 
Bedside tests
The urine dipstick test is a good example of a bedside test that can 
assist with diagnosing bacterial infection. The absence of nitrites 
or leucocytes makes urinary tract infection very unlikely, although 
pyuria in particular may have many alternative causes. Another 
routinely used bedside test is wet prep microscopy for the diagnosis 
of sexually transmitted infections in women. A bedside Gram stain 
can be extremely helpful for identifying Gram-negative diplococci 
in a joint aspirate to confirm gonoccocal arthritis,[4] or similarly 
for making a rapid diagnosis of meningococcaemia from a skin 
scraping of a petechial rash.[5] Unfortunately, these office tests are 
not often performed, even though they require minimal training 
and are cheap. 
Radiographs usually provide nonspecific evidence of infection, 
such as infiltrates on a chest radiograph or focal bony lysis suggesting 
osteomyelitis. More sophisticated radiological techniques such as 
computed tomography scanning or magnetic resonance imaging 
are sometimes required, but even these often lack the specificity to 
confidently rule in bacterial infection. Under these circumstances, it 
is usually necessary to use a laboratory and possibly a culture-based 
test to confirm the diagnosis.
Laboratory tests
There are a vast number of relevant laboratory tests that can be 
broadly divided into indirect and direct non-culture-based and 
culture-based tests, and nucleic acid amplification tests (NAATs). 
Indirect tests such as peripheral white cell count (WCC) and 
C-reactive protein (CRP) confirm the presence of inflammation 
when positive, but lack the specificity to differentiate bacterial from 
non-bacterial causes. However, high neutrophil count with left-shift 
and CRP >100 mg/mL suggest bacterial infection.[6] Negative results 
generally exclude inflammation and therefore bacterial infection. 
There has been great interest in developing more sophisticated point-
of-care (POC) tests that can accurately exclude bacterial infection. A 
number of useful tests are now available, including CRP, which have 
been shown in clinical trials to reduce antibiotic prescription for 
respiratory tract infections.[7] 
Procalcitonin (PCT) is 10 times more expensive than CRP or WCC 
tests, but more specific for bacterial infection. There is good evidence 
that antibiotics can safely be withheld, based on low PCT in acute 
meningitis, acute exacerbations of chronic obstructive pulmonary 
disease and upper respiratory tract infections.[8] PCT has no value in 
differentiating bacterial infection from tuberculosis[9] and has very 
limited value in sepsis.[10] Serial measurements can be used to decide 
when to discontinue antibiotics, particularly in the intensive care unit 
setting,[11] although use for this indication may be limited by cost. 
Current research is examining the complete host-proteome response 
to bacterial and viral infection to find signatures that can reliably 
differentiate the two. A recent study showed that the combination of 
tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), 
interferon gamma-induced protein-10, and CRP outperformed any 
individual proteins and routinely used clinical parameters and their 
combinations.[12]
Direct non-culture-based tests generally depend on identifying 
an antigen from an organism or a serological reaction to that 
antigen. These tests vary in their performance characteristics, but in 
general are specific for a particular bacterial infection in the correct 
clinical setting. An office-based rapid antigen test is available for the 
detection of group A Streptoccocus in children with sore throat; a 
positive test rules in the diagnosis with a high degree of certainty and 
can be used as a basis to confidently prescribe antibiotics.[13] Similarly, 
stool antigen tests accurately detect the presence of Helicobacter pylori 
infection,[14] facilitating the use of eradication therapy without the 
need for endoscopy. Antigen testing is sometimes preferred over 
culture for diagnosing bacterial infection due to fastidious or unusual 
organisms – Legionella pneumonia being a good example. A drawback 
of many antigen tests is reduced sensitivity compared with culture, 
and in severe or life-threatening illness this cannot reliably exclude 
infection. An example is bacterial meningitis, where a positive 
meningococcal[15] or pneumococcal antigen[16] test on cerebrospinal 
fluid is excellent at confirming those infections, but a negative test is 
insufficient for discontinuing empiric therapy. Another drawback of 
antigen tests is their inability to provide antimicrobial susceptibility 
data; therefore, even if pneumococcal meningitis is diagnosed on the 
basis of an antigen test, ceftriaxone will have to be continued until 
minimum inhibitory concentrations of penicillin can be determined 
from a cultured isolate. 
Serological tests are sometimes used to diagnose infections caused 
by bacteria that are difficult to culture. Certain classic tests are 
unreliable and should not be used, such as the Widal reaction 
for typhoid. Problems with serology include cross-reactivity with 
other antigens, particularly when measuring IgM, which reduces 
specificity, and false-negatives in early infection, which reduce 
sensitivity. Examples of serological tests used in clinical practice to 
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guide treatment are those for Rickettsia in suspected tick bite fever 
and amoebic serology in liver abscess. For some infections the 
diagnosis is only confirmed when comparing serological titres from a 
sample taken at the time of disease with a convalescent sample taken 
after the patient has recovered. This information is too late to change 
patient management, but can be useful epidemiologically. 
Culture-based tests are the basis of modern microbiology and 
are usually considered the reference standard with which other 
diagnostic tests are compared. However, cultures are seldom used 
in clinical practice to make an initial diagnosis of bacterial infection 
and rarely influence decisions about whether to initiate empiric 
antibiotic therapy; these are clinical decisions, influenced by findings 
on examination and supported by nonspecific bedside and laboratory 
tests. Culture results, which usually take at least 48 - 72 hours to become 
available, are then generally used to focus or discontinue antibiotics. 
Exceptions to this rule are patients who are clinically stable enough for 
antibiotic therapy to be delayed, and conditions such as pyrexia of 
unknown origin or suspected subacute bacterial endocarditis, where 
culturing of organisms is usually required before antibiotics can be 
initiated. 
The performance of cultures is influenced by the type and site 
of infection, e.g. the sensitivity of blood cultures for detecting an 
organism in uncomplicated cellulitis is extremely poor because 
of the small risk of bacteraemia in this condition.[17] In septic 
shock, however, the probability of a positive blood culture is about 
65%. Although cultures are usually considered to have a high 
specificity, inappropriate indications or poor sampling technique may 
diminish this greatly.[18] Examples of unreliable culture results include 
superficial skin swabs or urine collected from long-term indwelling 
catheters. 
Standard culture techniques generally require 48 - 72 hours to pro-
vide final results, whereas NAATs have the potential to reduce this 
window to a few hours. The most widely available is polymerase 
chain reaction (PCR), which relies on amplification and identification 
of nuclear material. NAATs provide the greatest advantage in terms 
of turnaround time when they can be performed directly on clinical 
specimens, such as a stool sample for Clostridium difficile.[19] Other PCRs 
require the organism to first be cultured from a clinical specimen, 
which necessarily increases the time to a result. Detailed information 
about the infection can be obtained from PCR, e.g. the FilmArray 
blood culture identification panel tests for 24 organisms and multiple 
resistance genes.[20] The degree of complexity associated with performing 
the test also varies, e.g. the GeneXpert system (Cepheid, Sunnyvale, CA, 
USA) is almost fully automated, requiring samples to be added to 
sealed cartridges that contain all the reagents for the reaction. More 
complex systems require highly skilled staff working in high-level 
laboratories, which increase costs and turnaround time.
Peptide nucleic acid fluorescent in situ hybridisation (PNA FISH) 
(AdvanDx, Woburn, Mass., USA) uses fluorescence-labelled synthetic 
oligonucleotide probes that bind to species-specific ribosomes and 
can be detected using a fluorescence microscope. Modern platforms 
can perform tests on blood cultures as soon as they become positive, 
giving a result within 30 minutes so that Gram stain and species 
identification results can be released simultaneously.
New technologies
New technologies that are likely to emerge as important diagnostic 
tools in future include nanoparticle probe technology and 
matrix-assisted laser desorption/ionisation time-of-flight mass 
spectrometry (MALDI-TOFMS). Nanosphere’s Verigene Gram-
positive (BC-GP) blood culture assay is performed directly on 
positive blood cultures using nucleic acid extraction and PCR 
amplification. Target DNA is then hybridised to oligonucleotides 
on a microarray with automated qualitative analysis. The test was 
approved by the US Food and Drug Administration in 2014 and 
currently has the ability to identify 10 Gram-positive and 8 Gram-
negative organisms along with multiple resistance genes. Currently, 
two MALDI-TOFMS platforms are available in the USA, MALDI 
Biotyper (Bruker Corporation, Billerica, Mass.) and VitekMS 
System (bio-Mérieux, Durham, NC). MALDI-TOF performs MS 
on target molecules following ionisation and disintegration; these 
patterns are compared with known organism fingerprints. It is 
capable of analysing thousands of samples from specimens per day, 
including blood, sputum and urine. Another promising infection 
testing platform that uses PCR followed by electrospray ionisation 
MS (PCR/ESI-MS) technology is able to rapidly detect >800 bacteria, 
including unculturable organisms and three classes of antibiotic 
resistance markers, directly from clinical specimens. In a recent 
study of 331 blood samples it was able to detect twice as many 
organisms as culture.[21] 
Conclusion
Clinicians must use a combination of clinical signs, bedside tests and 
laboratory investigations to diagnose bacterial infection. Knowledge 
of the types of tests available and how to use them appropriately 
are important tools in improving patient outcomes and rational 
antibiotic prescribing.
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